{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:49:23Z","timestamp":1788544163884,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"abstract":"<jats:p>We previously demonstrated that increased expression of the <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> gene is associated with hippocampal vulnerability in Alzheimer\u2019s disease (AD) brains. <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> was further demonstrated to be a novel tau-binding partner that colocalizes within neurofibrillary tangles. Our goal was to determine whether genetic variants in the <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> gene contributed to clinicopathologic phenotypes in AD. To screen for <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> variants, we sequenced 103 autopsy-confirmed young-onset AD cases with a positive family history of cognitive decline. To further assess the frequency of a rare missense variant, <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> p.E228Q, we screened an additional 1114 neuropathologically diagnosed AD cases. To provide neuropathologic context in AD, we immunohistochemically evaluated <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> and tau in a <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> p.E228Q variant carrier and a matched noncarrier. In the initial <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> screen, we observed 1 individual with a rare missense variant (rs140138746) that resulted in an amino acid change (p.E228Q). In our AD validation cohort, we identified an additional 5 carriers of this variant, resulting in an allelic frequency of 0.0021. There was no significant difference between <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> p.E228Q carriers and noncarriers in terms of demographic or clinicopathologic characteristics. Although not significant, on average <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> p.E228Q carriers were 5 years younger at age of disease onset than noncarriers (median: 66 [60\u201373] vs 71 [63\u201377] years, <jats:italic toggle=\"yes\">P<\/jats:italic> = .351). In addition, <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> p.E228Q carriers exhibited a longer disease duration than noncarriers that approached significance (median: 12 [10\u201315]) vs 9 [6\u201312] years, <jats:italic toggle=\"yes\">P<\/jats:italic> = .079). More severe neuronal loss was observed in the locus coeruleus, hippocampus, and amygdala of the <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> p.E228Q carrier compared to noncarrier, although no significant difference in SERPINA5-immunopositive lesions was observed. Throughout the AD brain in either carrier or noncarrier, areas with early pretangle pathology or burnt-out ghost tangle accumulation did not reveal <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic>-immunopositive neurons. Mature tangles and newly formed ghost tangles appeared to correspond well with <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic>-immunopositive tangle-bearing neurons. <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> gene expression was previously associated with disease phenotype; however, our findings suggest that <jats:italic toggle=\"yes\">SERPINA5<\/jats:italic> genetic variants may not be a contributing factor to clinicopathologic differences in AD. SERPINA5-immunopositive neurons appear to undergo a pathologic process that corresponded with specific levels of tangle maturity.<\/jats:p>","DOI":"10.1097\/md.0000000000034017","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:02:09Z","timestamp":1686938529000},"page":"e34017","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer\u2019s disease: A cross-sectional study"],"prefix":"10.1097","volume":"102","author":[{"given":"Billie J.","family":"Matchett","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Lincoln","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoleta","family":"Tamvaka","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney A.","family":"Labuzan","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany N.","family":"Hicks Sirmans","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Moloney","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Helminger","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"},{"name":"Paracelsus Medical University, Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Hinkle","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janisse","family":"Cabrera-Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Wickland","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Heckman","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Younkin","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva M.","family":"Carrasquillo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Duara","sequence":"additional","affiliation":[{"name":"Wien Center for Alzheimer\u2019s Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill R.","family":"Graff-Radford","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Pottier","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Ertekin-Taner","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"},{"name":"Department of Neurology, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"},{"name":"Applied and Translational Neurogenomics, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium"},{"name":"Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-2545","authenticated-orcid":false,"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach.","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study.","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/s41467-021-22399-3","article-title":"Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer\u2019s disease.","volume":"12","author":"Crist","year":"2021","journal-title":"Nat Commun"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research.","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimers Dement"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9258(18)33235-6","article-title":"Protein C inhibitor. purification from human plasma and characterization.","volume":"258","author":"Suzuki","year":"1983","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"R6-20250504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.12252","article-title":"Thrombin inhibition by the serpins.","volume":"11","author":"Huntington","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1538-7836.2008.03181.x","article-title":"The multi-functional serpin, protein C inhibitor: beyond thrombosis and hemostasis.","volume":"6","author":"Suzuki","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-1119(96)00681-6","article-title":"Molecular cloning and sequence analysis of the mouse protein C inhibitor gene.","volume":"186","author":"Zechmeister-Machhart","year":"1997","journal-title":"Gene"},{"key":"R9-20250504","first-page":"343","article-title":"Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome I4q32.1.","volume":"52","author":"Billingsley","year":"1993","journal-title":"Am J Hum Genet"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jalz.2018.12.013","article-title":"Ethnoracial differences in Alzheimer\u2019s disease from the Florida autopsied multi-ethnic (FLAME) cohort.","volume":"15","author":"Santos","year":"2019","journal-title":"Alzheimers Dement"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00401-019-01962-9","article-title":"Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.","volume":"137","author":"Pottier","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome.","volume":"47","author":"Rentzsch","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans.","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000362926","article-title":"Risk factors that affect life expectancy in Alzheimer\u2019s disease: a 15-year follow-up.","volume":"38","author":"Wattmo","year":"2014","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD.","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease.","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.","volume":"65","author":"Uchikado","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/bib\/bby039","article-title":"Regulatory variants: from detection to predicting impact.","volume":"20","author":"Rojano","year":"2019","journal-title":"Brief Bioinform"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:09:35Z","timestamp":1746320975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":21,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034017","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}